Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Chem Pharm Bull (Tokyo) ; 67(10): 1144-1151, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31582634

RESUMEN

Definitive screening design (DSD) is a new class of small three-level experimental design that is attracting much attention as a technical tool of a quality by design (QbD) approach. The purpose of this study is to examine the usefulness of DSD for QbD through a pharmaceutical study on the preparation of ethenzamide-containing orally disintegrating tablet. Model tablets were prepared by directly compressing the mixture of the active pharmaceutical ingredient (API) and excipients. The five evaluated factors assigned to DSD were: the contents of API (X1) and lubricant (X2), and the compression force (X3) of the tableting process, the mixing time (X4), and the filling ratio of powder in the V-type mixer (X5). After tablet preparation, hardness and disintegration time were measured. The same experiments were performed by using the conventional design of experiments [i.e., L8 and L16 orthogonal array designs and central composite design (CCD)]. Results showed that DSD successfully clarified how various factors contribute to tablet properties. Moreover, the analysis result from DSD agreed well with those from the L8 and L16 experiments. In additional experiments, response surfaces for tablet properties were created by DSD. Compared with the response surfaces created by CCD, DSD could produce reliable response surfaces for its smaller number of experiments. We conclude that DSD is a powerful tool for implementing pharmaceutical studies including the QbD approach.


Asunto(s)
Diseño de Fármacos , Preparaciones Farmacéuticas/química , Composición de Medicamentos , Evaluación Preclínica de Medicamentos , Preparaciones Farmacéuticas/administración & dosificación , Propiedades de Superficie , Comprimidos/administración & dosificación , Comprimidos/química
2.
Int J Pharm ; 563: 406-412, 2019 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-30978488

RESUMEN

The time-temperature superposition principle (TTSP) was applied to the destabilization kinetics of a pharmaceutical emulsion. The final goal of this study is to predict precisely the emulsion stability after long-term storage from the short-period accelerated test using TTSP. As the model emulsion, a cream preparation that is clinically used for the treatment of pruritus associated with chronic kidney disease was tested. After storage at high temperatures ranging from 30 to 45 °C for designated periods, the emulsion state was monitored using magnetic resonance imaging, and then the phase separation behaviors observed were analyzed according to the Arrhenius approach applying TTSP. The Arrhenius plot showed a biphasic change around 35 °C, indicating that the separation behaviors of the sample were substantially changed between the lower (30-35 °C) and higher (35-45 °C) temperature ranges. This study also monitored the coalescence behavior using a backscattered light measurement. The experiment verified that the destabilization was initiated by coalescence of oil droplets and then it eventually led to obvious phase separation via creaming. Furthermore, we note the coalescence kinetics agreed well with the phase separation kinetics. Therefore, in the case of the sample emulsion, the coalescence behavior has a dominant influence on the destabilization process. This study offers a profound insight into the destabilization process of pharmaceutical emulsions and demonstrates the promising applicability of TTSP to pharmaceutical research.


Asunto(s)
Emulsiones/química , Crema para la Piel/química , Alcanfor/química , Difenhidramina/química , Estabilidad de Medicamentos , Etanol/química , Cinética , Mentha , Mentol/química , Aceites de Plantas/química , Temperatura , Timol/química , Factores de Tiempo
3.
Chem Pharm Bull (Tokyo) ; 66(10): 959-966, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30270242

RESUMEN

Although many in silico models were reported to predict the skin permeation of drugs from aqueous solutions, few studies were founded on the in silico estimation models for the skin permeation of drugs from neat oil formulations and o/w emulsions. In the present study, the cumulative amount of a model lipophilic drug, flurbiprofen (FP), that permeated through skin was determined from 12 different kinds of ester oils (Qoil) and an in silico model was developed for predicting the skin permeation of FP from these ester oils. Thus, the obtained Qoil values were well predicted with the FP solubility in the oils (Soil), the amount of FP uptake into the stratum corneum (SCoil) and molecular descriptors of dipolarity/polarizability (π2H) and molecular density. This model suggests that the thermodynamic activities of FP both in the formulations and skin are the key factors for predicting the skin permeation of FP from the ester oils. In addition, a high linear relationship was observed in the double-logarithm plots between the Qoil and the cumulative amount of FP permeated through skin from 20% ester oil in water emulsion (Qemul20%). Furthermore, the skin permeations of FP from 5 and 10% ester oil in water emulsions, Qemul5% and Qemul10%, respectively, were also predicted by the horizontal translation of the y-axis intercept of the liner equation for the relation between the Qoil and Qemul20%. These prediction methods must be helpful for designing topical oily and/or o/w emulsion formulations having suitable and high skin permeation rate of lipophilic drugs.


Asunto(s)
Ésteres/química , Flurbiprofeno/metabolismo , Aceites de Plantas/química , Piel/metabolismo , Animales , Oído , Emulsiones/química , Flurbiprofeno/química , Absorción Cutánea , Solubilidad , Porcinos , Agua/química
4.
Drug Dev Ind Pharm ; 34(11): 1238-45, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18720142

RESUMEN

The aim of this study was to evaluate and optimize preparative parameters for floatable theophylline microspheres prepared by the emulsion-solvent evaporation method. A three-factor three-level Box-Behnken design was employed using amount of poor solvent, temperature-increase rate and drug loading as independent factors, and percentage floating at 3 h and time required for 50% drug release as dependent variables. Simultaneous optimization of the parameters for maximum buoyancy and desirable drug release was conducted using a partitioned artificial neural network. A microsphere using 27.6% of drug loading, 0.29 degrees C/min of temperature-increase rate, and 1.7 mL of poor solvent was identified for maximizing buoyancy and sustaining drug release.


Asunto(s)
Química Farmacéutica/métodos , Preparaciones de Acción Retardada/química , Microesferas , Solventes/química , Preparaciones de Acción Retardada/farmacocinética , Evaluación Preclínica de Medicamentos/métodos , Tamaño de la Partícula , Solventes/farmacocinética
5.
Chem Pharm Bull (Tokyo) ; 55(8): 1164-8, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17666838

RESUMEN

For the treatment of chronic inflammation in the oral cavity, we attempted to develop bioadhesive tablets of bovine lactoferrin (B-LF). Pectin was used as a bioadhesive polymer, and the influence of the degree of esterification and the molecular weight of pectins on the characteristics of B-LF tablets were investigated. Concerning bioadhesive force, a tendency increasing the value according to increase of the esterification of the pectin was confirmed. Sustained release of B-LF from the tablets was observed as the esterification increased, and a possibility for prediction of the time required to release 50% of B-LF by using the equation given by the degree of esterification and the logarithm of the molecular weight was suggested. Pectin cross-linked with Ca(2+) (Ca-PC) was also used for the preparation of the B-LF tablets. Prolonged release of B-LF from the tablets was observed as the Ca(2+) in Ca-PC increased. Our findings suggest that pectin with a high degree of esterification is suitable as a bioadhesive polymer since high bioadhesive force and sustained release are shown. Furthermore, a possibility that the B-LF release could be controlled by adjusting the Ca(2+) concentration in Ca-PC was suggested.


Asunto(s)
Lactoferrina/administración & dosificación , Pectinas/química , Absorción , Adhesivos , Animales , Composición de Medicamentos , Excipientes , Técnicas In Vitro , Lactoferrina/química , Masculino , Membranas/química , Ratones , Peso Molecular , Análisis de Regresión , Solubilidad , Comprimidos , Resistencia a la Tracción , Viscosidad
6.
Int J Pharm ; 287(1-2): 39-46, 2004 Dec 09.
Artículo en Inglés | MEDLINE | ID: mdl-15541910

RESUMEN

The principal component of aqueous extract of jelly fig (Ficus awkeotsang Makino) seeds is a pectin-type polysaccharide, gelling even at room temperature without adding any sugars, acids or ions. The objective of this study was to evaluate jelly fig extract (JF) as a matrix base for sustained release tablets. Drug release profile from JF tablet was examined using theophylline as a model drug, compared with those from USP graded pectin (USP-P). Release profile from JF tablet was a sustained release pattern and not affected by pH of medium. USP-P tablet showed a similar release profile of JF tablet, however, the release mechanisms differed. Matrix erosion studies revealed that the percentage of drug released from USP-P tablet was proportional to that of matrix eroded. On the other hand, JF tablet was eroded up to 50% of matrix for 4h and showed a constant value thereafter. According to water uptake studies, JF tablet showed an initial burst swelling followed by slow water uptake, suggesting diffusion-controlled kinetics in later phase. Moreover, theophylline release rate from JF tablet was modified by drug content in the tablet, increasing with decrease in drug amount. These findings indicated JF was a potential hydrophilic matrix for controlled drug delivery.


Asunto(s)
Preparaciones de Acción Retardada , Ficus , Extractos Vegetales/administración & dosificación , Concentración de Iones de Hidrógeno , Pectinas/administración & dosificación , Solubilidad , Comprimidos
7.
Biol Pharm Bull ; 26(12): 1739-43, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14646182

RESUMEN

The significant inhibitory action of diclofenac formulated in mixed micelles of lecithin with cholate or deoxycholate was observed on the rat hind paw edema induced by carrageenan. In the primary stage, mixed micelle formulation of deoxycholate was more effective compared with that of cholate. However, in the final term, the inhibitory action was similar in both formulations. In a previous study, the flux of diclofenac was greater in the mixed micelle formulation of deoxycholate compared with that of cholate. It was suggested that the permeation rate of diclofenac through skin was proportional to the pharmacological activity. The hind paw edema was quickly inhibited when cyclic monoterpene such as d-limonene or l-menthol was included in the formulations. All the micelle formulations significantly decreased the value of AUC estimated the hind paw thickness-time profile. This suggests that the micelle formulation of cholate in addition to deoxycholate showed significant anti-inflammatory activity to hind paw edema of rats. Incorporation of d-limonene or l-menthol was more effective on the decrease of AUC. A pharmacological study revealed that micelle formulations were able to reduce the skin irritation of chemicals.


Asunto(s)
Administración Cutánea , Diclofenaco/farmacocinética , Composición de Medicamentos/métodos , Micelas , Monoterpenos/química , Animales , Ácidos y Sales Biliares/administración & dosificación , Ácidos y Sales Biliares/química , Disponibilidad Biológica , Transporte Biológico/fisiología , Carragenina/administración & dosificación , Carragenina/efectos adversos , Colatos/administración & dosificación , Colatos/farmacocinética , Ciclohexenos , Ácido Desoxicólico/administración & dosificación , Ácido Desoxicólico/farmacocinética , Diclofenaco/administración & dosificación , Evaluación Preclínica de Medicamentos , Edema/inducido químicamente , Edema/metabolismo , Edema/prevención & control , Miembro Posterior/efectos de los fármacos , Inyecciones , Irritantes/efectos adversos , Limoneno , Masculino , Mentol/administración & dosificación , Mentol/farmacocinética , Monoterpenos/administración & dosificación , Ratas , Ratas Wistar , Piel/efectos de los fármacos , Piel/fisiopatología , Absorción Cutánea/efectos de los fármacos , Terpenos/administración & dosificación , Terpenos/farmacocinética
8.
Int J Pharm ; 265(1-2): 95-102, 2003 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-14522122

RESUMEN

The purpose of this study was to examine the improvement of the bioavailability of glycyrrhizin (GL) via extra-vascular, i.e. oral, rectal, and nasal routes with or without the aid of an absorption enhancer in place of the vascular intravenous route in rats. Pharmacokinetic behavior following administration via vascular routes, i.e. the intravenous and portal-venous routes was examined in rats. The area under the plasma concentration-time curve (AUC) after administration of GL via the portal vein was decreased slightly, suggesting that the first elimination of GL in the liver may be one of the factors contributing to the low bioavailability after administration via the oral route. When GL was administered orally as a solution (30 mg/kg), the plasma concentration of GL was extremely low. However, after rectal or nasal administration of GL solution (30 mg/kg) with or without sodium caprate, the mean AUC value was remarkably increased compared with oral administration. In particular, the absolute bioavailability of GL after nasal administration was estimated to be approximately 20%, which was approximately 80-fold greater compared with after oral administration despite of the absence of an enhancer. Furthermore, the fatty acids co-administered orally with GL produced an increase in GL absorption in the following order: sodium caprate>sodiumlaurate>sodiumcaprylate>sodium oleate. These results indicate that the rectum and nasal cavity are useful administration routes for systemic delivery of GL. It was also found that the fatty acids were enhancers for the absorption of GL.


Asunto(s)
Adyuvantes Farmacéuticos/química , Ácidos Grasos/química , Ácido Glicirrínico/administración & dosificación , Absorción , Administración Intranasal , Administración Oral , Administración Rectal , Animales , Área Bajo la Curva , Disponibilidad Biológica , Ácido Glicirrínico/sangre , Ácido Glicirrínico/farmacocinética , Inyecciones Intravenosas , Masculino , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA